Tam AR, Zhang RR, Lung KC, Liu R, et al. Early treatment of high-risk hospitalized COVID-19 patients with a combination of interferon beta-1b and remdesivir: a phase 2 open-label randomized controlled trial. Clin Infect Dis 2022 Jun 28. pii: 6619124. doi: 10.1093.
PMID: 35762834